Gv 2016 Gp, L.p. - Net Worth and Insider Trading

Gv 2016 Gp, L.p. Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Gv 2016 Gp, L.p. owns 7 companies in total, including Magenta Therapeutics Inc (MGTA) , Arcus Biosciences Inc (RCUS) , and ARMO BioSciences Inc (ARMO) among others .

Click here to see the complete history of Gv 2016 Gp, L.p.’s form 4 insider trades.

Insider Ownership Summary of Gv 2016 Gp, L.p.

Ticker	Comapny	Transaction Date	Type of Owner
MGTA	Magenta Therapeutics Inc	2018-06-20	10 percent owner
RCUS	Arcus Biosciences Inc	2018-03-14	10 percent owner
ARMO	ARMO BioSciences Inc	2018-01-30	10 percent owner
		2017-11-15	10 percent owner
		2021-02-11	10 percent owner
		2021-09-30	10 percent owner
		2023-02-15	10 percent owner

Gv 2016 Gp, L.p. Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Gv 2016 Gp, L.p. Ownership Network

Ownership Network List of Gv 2016 Gp, L.p.

No Data

Ownership Network Relation of Gv 2016 Gp, L.p.

Gv 2016 Gp, L.p. Owned Company Details

What does Magenta Therapeutics Inc do?

Who are the key executives at Magenta Therapeutics Inc?

Gv 2016 Gp, L.p. is the 10 percent owner of Magenta Therapeutics Inc. Other key executives at Magenta Therapeutics Inc include director & 10 percent owner Peter Evan Harwin , director & 10 percent owner Tomas Kiselak , and director & 10 percent owner Fairmount Funds Management Llc .

Magenta Therapeutics Inc (MGTA) Insider Trades Summary

Over the past 18 months, Gv 2016 Gp, L.p. made no insider transaction in Magenta Therapeutics Inc (MGTA). Other recent insider transactions involving Magenta Therapeutics Inc (MGTA) include a net sale of 3,700,000 shares made by Third Rock Ventures Iv, L.p. ,

In summary, during the past 3 months, insiders sold 0 shares of Magenta Therapeutics Inc (MGTA) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 3,700,000 shares of Magenta Therapeutics Inc (MGTA) were sold and 0 shares were bought by its insiders, resulting in a net sale of 3,700,000 shares.

Magenta Therapeutics Inc (MGTA)'s detailed insider trading history can be found in Insider Trading Tracker table.

Magenta Therapeutics Inc Insider Transactions

No Available Data

What does Arcus Biosciences Inc do?

Who are the key executives at Arcus Biosciences Inc?

Gv 2016 Gp, L.p. is the 10 percent owner of Arcus Biosciences Inc. Other key executives at Arcus Biosciences Inc include See Remarks Jennifer Jarrett , director & 10 percent owner & President Juan C. Jaen , and 10 percent owner Gilead Sciences Inc .

Arcus Biosciences Inc (RCUS) Insider Trades Summary

Over the past 18 months, Gv 2016 Gp, L.p. made no insider transaction in Arcus Biosciences Inc (RCUS). Other recent insider transactions involving Arcus Biosciences Inc (RCUS) include a net sale of 223,626 shares made by Jennifer Jarrett , a net sale of 38,443 shares made by Juan C. Jaen , and a net sale of 8,506 shares made by Goeltz Ii Robert C. .

In summary, during the past 3 months, insiders sold 110,657 shares of Arcus Biosciences Inc (RCUS) in total and bought 0 shares, with a net sale of 110,657 shares. During the past 18 months, 286,423 shares of Arcus Biosciences Inc (RCUS) were sold and 16,248,095 shares were bought by its insiders, resulting in a net purchase of 15,961,672 shares.

Arcus Biosciences Inc (RCUS)'s detailed insider trading history can be found in Insider Trading Tracker table.

Arcus Biosciences Inc Insider Transactions

No Available Data

What does ARMO BioSciences Inc do?

Who are the key executives at ARMO BioSciences Inc?

Gv 2016 Gp, L.p. is the 10 percent owner of ARMO BioSciences Inc. Other key executives at ARMO BioSciences Inc include director & 10 percent owner Orbimed Advisors Llc , 10 percent owner Orbimed Capital Gp V Llc , and 10 percent owner Orbimed Capital Gp Iv Llc .

ARMO BioSciences Inc (ARMO) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of ARMO BioSciences Inc (ARMO) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of ARMO BioSciences Inc (ARMO) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

ARMO BioSciences Inc (ARMO)'s detailed insider trading history can be found in Insider Trading Tracker table.

ARMO BioSciences Inc Insider Transactions

No Available Data

What does X4 Pharmaceuticals Inc do?

Who are the key executives at X4 Pharmaceuticals Inc?

Gv 2016 Gp, L.p. is the 10 percent owner of X4 Pharmaceuticals Inc. Other key executives at X4 Pharmaceuticals Inc include Chief Scientific Officer Arthur Taveras , Chief Operating Officer Mary Dibiase , and See Remarks Adam S. Mostafa .

X4 Pharmaceuticals Inc (XFOR) Insider Trades Summary

Over the past 18 months, Gv 2016 Gp, L.p. made no insider transaction in X4 Pharmaceuticals Inc (XFOR). Other recent insider transactions involving X4 Pharmaceuticals Inc (XFOR) include a net sale of 401,923 shares made by Paula Ragan , a net sale of 113,683 shares made by Mary Dibiase , and a net sale of 401,921 shares made by Adam S. Mostafa .

In summary, during the past 3 months, insiders sold 131,822 shares of X4 Pharmaceuticals Inc (XFOR) in total and bought 0 shares, with a net sale of 131,822 shares. During the past 18 months, 1,158,291 shares of X4 Pharmaceuticals Inc (XFOR) were sold and 25,000 shares were bought by its insiders, resulting in a net sale of 1,133,291 shares.

X4 Pharmaceuticals Inc (XFOR)'s detailed insider trading history can be found in Insider Trading Tracker table.

X4 Pharmaceuticals Inc Insider Transactions

No Available Data

What does Decibel Therapeutics Inc do?

Who are the key executives at Decibel Therapeutics Inc?

Gv 2016 Gp, L.p. is the 10 percent owner of Decibel Therapeutics Inc. Other key executives at Decibel Therapeutics Inc include See Remarks James B Murphy , See Remarks Anna Trask , and director & See Remarks Laurence Reid .

Decibel Therapeutics Inc (DBTX) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Decibel Therapeutics Inc (DBTX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Decibel Therapeutics Inc (DBTX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Decibel Therapeutics Inc (DBTX)'s detailed insider trading history can be found in Insider Trading Tracker table.

Decibel Therapeutics Inc Insider Transactions

No Available Data

What does IonQ Inc do?

Who are the key executives at IonQ Inc?

Gv 2016 Gp, L.p. is the 10 percent owner of IonQ Inc. Other key executives at IonQ Inc include Chief Revenue Officer Rima Alameddine , director & President and CEO Peter Hume Chapman , and director & Chief Strategy Officer Jungsang Kim .

IonQ Inc (IONQ) Insider Trades Summary

Over the past 18 months, Gv 2016 Gp, L.p. made no insider transaction in IonQ Inc (IONQ). Other recent insider transactions involving IonQ Inc (IONQ) include a net sale of 104,634 shares made by Peter Hume Chapman , a net sale of 55,864 shares made by Thomas G. Kramer , and a net sale of 42,076 shares made by Jungsang Kim .

In summary, during the past 3 months, insiders sold 86,556 shares of IonQ Inc (IONQ) in total and bought 115,000 shares, with a net purchase of 28,444 shares. During the past 18 months, 720,604 shares of IonQ Inc (IONQ) were sold and 115,000 shares were bought by its insiders, resulting in a net sale of 605,604 shares.

IonQ Inc (IONQ)'s detailed insider trading history can be found in Insider Trading Tracker table.

IonQ Inc Insider Transactions

No Available Data

What does Starco Brands Inc do?

Who are the key executives at Starco Brands Inc?

Gv 2016 Gp, L.p. is the 10 percent owner of Starco Brands Inc. Other key executives at Starco Brands Inc include 10 percent owner Ah Parallel Fund Iv-q, L.p. , 10 percent owner Andreessen Horowitz Fund Iv, L.p. , and 10 percent owner A16z Seed-iii, Llc .

Starco Brands Inc (STCB) Insider Trades Summary

Over the past 18 months, Gv 2016 Gp, L.p. made no insider transaction in Starco Brands Inc (STCB). Other recent insider transactions involving Starco Brands Inc (STCB) include a net purchase of 203,610 shares made by Ross Jeffery Sklar ,

In summary, during the past 3 months, insiders sold 0 shares of Starco Brands Inc (STCB) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Starco Brands Inc (STCB) were sold and 203,610 shares were bought by its insiders, resulting in a net purchase of 203,610 shares.

Starco Brands Inc (STCB)'s detailed insider trading history can be found in Insider Trading Tracker table.

Starco Brands Inc Insider Transactions

No Available Data

Gv 2016 Gp, L.p. Mailing Address

Above is the net worth, insider trading, and ownership report for Gv 2016 Gp, L.p.. You might contact Gv 2016 Gp, L.p. via mailing address: 1600 Amphitheatre Parkway, Mountain View Ca 94043.

Discussions on Gv 2016 Gp, L.p.

No discussions yet.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us ETF Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.